Arkolith/Insider Trading/DNLI/Form 4

Ho Carole

Chief Medical OfficerDenali Therapeutics Inc. (DNLI) · full profile →Form 4 · filed Aug 14, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$52K
Net Open-Market Flow
-$52K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 13, 2025Sell(S)806$14.64$12K217K
Aug 12, 2025Sell(S)3K$13.58$40K217K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001714899-25-000176) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML